Psychosomatic Medicine Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Younger, J. W.
Right arrow Articles by Keenum, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Younger, J. W.
Right arrow Articles by Keenum, A. J.
Related Collections
Right arrow Blood Pressure
Right arrow Psychophysiology
Right arrow Stress and Coping
Psychosomatic Medicine 68:734-741 (2006)
© 2006 American Psychosomatic Society


ORIGINAL ARTICLES

Effects of Naltrexone on Repressive Coping and Disclosure of Emotional Material: A Test of the Opioid-Peptide Hypothesis of Repression and Hypertension

Jarred W. Younger, PhD, Kathleen A. Lawler-Row, PhD, Krista A. Moe, BS, Anna L. Kratz, MA and Amy J. Keenum, DO, PharmD

From the Division of Pain Management, Department of Anesthesia, Stanford University School of Medicine, Palo Alto, California (J.W.Y.); the Department of Psychology, University of Tennessee, Knoxville, Tennessee (K.A.L.-R.); the Department of Educational and Counseling Psychology, University of Kentucky, Lexington, Kentucky (K.A.M.); the Department of Psychology, Arizona State University, Tempe, Arizona (A.L.K.); and the Department of Family Medicine, University of Tennessee Graduate School of Medicine, Knoxville, Tennessee (A.J.K.).

Objective: The present study was designed to assess the role of endogenous opioids in the relationship of hypertension to repressive coping.

Methods: Ten hypertensive and 8 normotensive males were given either the opioid antagonist naltrexone or placebo in a randomized, double-blind fashion over the course of four laboratory sessions. Measures of repression and disclosure were completed and blood pressure was assessed during a laboratory stressor protocol.

Results: Opioid antagonism reduced repression and increased disclosure only in the hypertensive group. Also, opioid antagonism increased stress-related systolic blood pressure only in the hypertensive group.

Conclusion: The results support the hypothesis that endogenous opioid dysregulation underlies both hypertension and repressive phenomena.

Key Words: hypertension • repression • disclosure • opioids • comorbidity • naltrexone

Abbreviations: DBP = diastolic blood pressure; SBP = systolic blood pressure; POMS = Profile of Mood States; LCC = Life Concerns Checklist; MAS = Taylor Manifest Anxiety Scale; MCSDS = Social Desirability Scale; TAS = Toronto Alexithymia Scale.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Psychosomatic Society